Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
With
Sun Yat-Sen University Cancer Center
The best proper doses of RT in combined modality treatments (CMT) for localized DLBCL is still undetermined. Existing treatment guidelines recommend 40Gy or above as the standard treatment dosage. However, there were large-scaled clinical trials implying smaller doses such as 30Gy may be equivalent effective. Lowering radiation doses can decrease treatment toxicities and radiotherapy-induced diseases, which has been conformed by HD13 study for Hodgkin's Lymphoma. It may even retain the truth when modern era radiation techniques are involved and especially in patients achieving CR after chemotherapy. A comprehensive, prospective dose-comparing study is needed.
Age
15–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Written informed consent obtained before any trial-specific procedure.
5. Complete response after chemotherapy, defined as the absence of clinical or imaging evidence of active disease, or a Deauville score of 1-3 on PET/CT.
6. An interval of less than 90 days between completion of chemotherapy and radiotherapy.
7. Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.
8. Able to receive conformal radiotherapy and to complete the required follow-up.
You may not be if
1. HIV seropositivity.
2. Primary lymphoma of the central nervous system, skin, or testis.
3. Transformation from another indolent lymphoma.
4. Previous malignancy other than cervical carcinoma in situ.
5. Hepatic or cardiac failure.
6. Any concurrent condition precluding protocol treatment.
7. Chemotherapy or radiotherapy before trial enrolment.